---
figid: PMC3356574__nihms374798f3
figlink: /pmc/articles/PMC3356574/figure/F3/
number: F3
caption: A model of the signaling pathways regulating radiation-induced bystander
  effects through expression and secretion of soluble biologically active factors.
  α-particle irradiation caused DNA damage, which induces ATM activation in normal
  and cancer cells. ATM further activates the NF-κB pathway, which targets gene expression
  of numerous cytokines and COX2. Cytokines initiate specific signaling pathways in
  directly irradiated and bystander cells resulting in the secondary activation of
  IKK-NF-κB, JAK2-STAT3 and the MAPK pathways with the subsequent induction of cytokine,
  COX2 and inducible Nitric Oxide Synthase (iNOS) gene expression. COX-2-produced
  PGE2 is involved in regulation of reactive oxygen species (ROS) production, iNOS
  controls synthesis of NO. Effects of ROS and Nitric oxide (NO) in the mitochondrial
  damage and bystander response were previously described []. On the other hand, NF-κB
  regulates expression of numerous genes controlling a general cell survival and anti-apoptotic
  activity. Exogenous IGF-1 via ligation of IGF-1R activates the PI3K-AKT pathway
  that using suppression of GSK3β stabilizes β-catenin protein levels; LEF1--β-catenin
  heterodimer goes to the nucleus and further controls gene expression. Furthermore,
  AKT controls numerous general metabolic, survival and anti-apoptotic functions in
  the cell. IGFBP-3 stabilizes the exogenous IGF-1 and extends its action time further
  activating the basal PI3K-AKT pathway. An additional level of cell-cell communications
  is a usage of gap junctions that could transmit signaling molecules, such as NO.
pmcid: PMC3356574
papertitle: 'Radiation Induced Non-targeted Response: Mechanism and Potential Clinical
  Implications.'
reftext: Tom K. Hei, et al. Curr Mol Pharmacol. ;4(2):96-105.
pmc_ranked_result_index: '4394'
pathway_score: 0.9737142
filename: nihms374798f3.jpg
figtitle: The signaling pathways regulating radiation-induced bystander effects through
  expression and secretion of soluble biologically active factors
year: ''
organisms: Homo sapiens
ndex: b97b289e-debe-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3356574__nihms374798f3.html
  '@type': Dataset
  description: A model of the signaling pathways regulating radiation-induced bystander
    effects through expression and secretion of soluble biologically active factors.
    α-particle irradiation caused DNA damage, which induces ATM activation in normal
    and cancer cells. ATM further activates the NF-κB pathway, which targets gene
    expression of numerous cytokines and COX2. Cytokines initiate specific signaling
    pathways in directly irradiated and bystander cells resulting in the secondary
    activation of IKK-NF-κB, JAK2-STAT3 and the MAPK pathways with the subsequent
    induction of cytokine, COX2 and inducible Nitric Oxide Synthase (iNOS) gene expression.
    COX-2-produced PGE2 is involved in regulation of reactive oxygen species (ROS)
    production, iNOS controls synthesis of NO. Effects of ROS and Nitric oxide (NO)
    in the mitochondrial damage and bystander response were previously described [].
    On the other hand, NF-κB regulates expression of numerous genes controlling a
    general cell survival and anti-apoptotic activity. Exogenous IGF-1 via ligation
    of IGF-1R activates the PI3K-AKT pathway that using suppression of GSK3β stabilizes
    β-catenin protein levels; LEF1--β-catenin heterodimer goes to the nucleus and
    further controls gene expression. Furthermore, AKT controls numerous general metabolic,
    survival and anti-apoptotic functions in the cell. IGFBP-3 stabilizes the exogenous
    IGF-1 and extends its action time further activating the basal PI3K-AKT pathway.
    An additional level of cell-cell communications is a usage of gap junctions that
    could transmit signaling molecules, such as NO.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RASA1
  - ATM
  - TNF
  - IGF1
  - TNFRSF10B
  - FOSL1
  - JUN
  - JUNB
  - PIK3CA
  - IGFBP3
  - PIK3R6
  - PIK3R5
  - CXCL8
  - RELB
  - AKT3
  - IL1B
  - NFKB1
  - JUND
  - TNFSF10
  - IL6
  - PIK3R4
  - PIK3CG
  - FOSB
  - IGF1R
  - TNFRSF1A
  - FOSL2
  - RELA
  - REL
  - FOS
  - SDCBP2
  - NFKB2
  - AKT1
  - IL1R1
  - AKT2
  - PIK3CB
  - LEF1
  - JAK2
  - STAT3
  - IL1A
  - PIK3R3
  - PIK3CD
  - IL33
  - PGE2
  - Cancer
genes:
- word: Gap
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: IL1,IL6,IL8,IL33,TNF,TRAIL
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IGF-1/IGFBP3
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: DR5
  symbol: DR5
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10B
  entrez: '8795'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IGF-1/IGFBP3
  symbol: IGFBP3
  source: hgnc_symbol
  hgnc_symbol: IGFBP3
  entrez: '3486'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IL1,IL6,IL8,IL33,TNF,TRAIL
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: NF-KB•
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: NF-KB/ikB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: TRAIL
  symbol: TRAIL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: IL1,IL6,IL8,IL33,TNF,TRAIL
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: TNF-R1
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: TNFa
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: NF-KB•
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: NF-KB•
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB•
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: ST2
  symbol: ST-2
  source: hgnc_alias_symbol
  hgnc_symbol: SDCBP2
  entrez: '27111'
- word: NF-KB•
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IL1-R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: '*LEF1'
  symbol: LEF1
  source: hgnc_symbol
  hgnc_symbol: LEF1
  entrez: '51176'
- word: JAK2-
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Stat3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL33,
  symbol: IL33
  source: hgnc_symbol
  hgnc_symbol: IL33
  entrez: '90865'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3356574__F3
redirect_from: /figures/PMC3356574__F3
figtype: Figure
---
